Not provided
Not provided
Not provided
Not provided
Enrollment goals not being met.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to compare the 10-year Knee Society Score (KSS) functional results of the Triathlon PKR Unicondylar Knee to the 10-year Knee Society Score (KSS) functional results of the Triathlon Cruciate Retaining (CR) Total Knee.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Triathlon PKR | Other | All subjects enrolled will receive the Triathlon PKR device. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Triathlon PKR | Device | Triathlon PKR is a unicondylar knee resurfacing system designed to replace a single osteoarthritic compartment of a patient's natural knee. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Investigation of Clinical Performance and Patient Outcome With the Functional Knee Society Score (KSS). | The Knee Society Score (KSS) consists of two distinct sub-scores: one for pain, range of motion, joint stability and alignment (Pain/Motion KSS) and one for distance walked, stair climbing and walking aids (Functional KSS). This outcome measure was only for the KSS Function Score at 10-years. The KSS Function score subscale is 0-100, with 100 representing a better outcome. Although the specific scores are not distinguished as "excellent", "good", "fair", or "poor", a higher value represents a better outcome. | 10 years |
| Measure | Description | Time Frame |
|---|---|---|
| 10-years Kaplan Meier Survival Analysis | For the purpose of this study the Kaplan-Meier survival curves are a statistical method to estimate the survival function from lifetime data of a knee replacement after treatment. Survivorship is defined as a percentage of knees free of any component revision for any reason. | 10-years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| R. David Heekin, M.D. | St. Vincent's Medical Center | Principal Investigator |
| Marco Tinius, MD | Praxisklinik Stollberg | Principal Investigator |
| Marco Schiraldi, MD | Presidlo Ospedaliero Civile Santi Antonio e Biagio | Principal Investigator |
| Brian Aros, MD | Mansfield Orthopaedics | Principal Investigator |
| Fabio Orozco, MD | Rothman Institute | Principal Investigator |
| Matthew Phillips, MD | Department of Orthopaedic Surgery, Kaleida Health, Buffalo General Hospital | Principal Investigator |
| Peter Bonutti, MD | Bonutti Clinic | Principal Investigator |
| Soren Toksvig-Larsen, MD | Hassleholm Sygehus Ortopaedkirurgisk afd. | Principal Investigator |
| Brett Greenky, MD | Syracuse Orthopedic Specialists | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Heekin Orthopaedic Institute for Research, Inc. | Jacksonville | Florida | 32204 | United States | ||
| Rothman Institute |
Of the 111 participants enrolled, there were 23 cases that were censored due to not having the study device, surgery canceled or an inclusion exclusion violation. Therefore, 89 knees in 88 participants are followed who did receive the study device and met protocol criteria. Those applicable data are reflected in this record.
There were 112 knees in 111 patients that were enrolled in the study (one bilateral case).
| ID | Title | Description |
|---|---|---|
| FG000 | Triathlon PKR Unicompartmental Knee | All subjects enrolled will receive the Triathlon PKR device. Triathlon PKR: Triathlon PKR is a unicondylar knee resurfacing system designed to replace a single osteoarthritic compartment of a patient's natural knee for a primary replacement indication. |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Triathlon PKR | All subjects enrolled will receive the Triathlon PKR device. Triathlon PKR: Triathlon PKR is a unicondylar knee resurfacing system designed to replace a single osteoarthritic compartment of a patient's natural knee. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Investigation of Clinical Performance and Patient Outcome With the Functional Knee Society Score (KSS). | The Knee Society Score (KSS) consists of two distinct sub-scores: one for pain, range of motion, joint stability and alignment (Pain/Motion KSS) and one for distance walked, stair climbing and walking aids (Functional KSS). This outcome measure was only for the KSS Function Score at 10-years. The KSS Function score subscale is 0-100, with 100 representing a better outcome. Although the specific scores are not distinguished as "excellent", "good", "fair", or "poor", a higher value represents a better outcome. | Due to early study termination the primary outcome was only reached for a minimal number of participants (12) reaching 10 years. These only included prospective cases. No retrospective cases reached the 10-year time interval. | Posted | Mean | Standard Deviation | units on a scale | 10 years | Knees | Knees |
|
This study required that all operative site adverse events, regardless of seriousness, and serious systemic events, be reported from enrollment to the 10-year postoperative time interval.
The date of occurrence, date diagnosed, type of complication/adverse event and treatment were collected.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Operative Adverse Events | Operative site adverse events are reported by knee because in the case of bilateral participants (this is when one participant has both knees enrolled in the study), an event can occur in one knee, both knees or the same knee at different times and are counted separately for this reason. |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Non-operative | Cardiac disorders | MedDRA | Non-systematic Assessment |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Operative | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment |
After 13-years the enrollment goal was not met. This led to a protocol amendment to include retrospective cases. These cases were combined with the initial prospective cases and followed prospectively for the planned observation time. This study does not compare prospective to retrospective cases. The retrospectively enrolled cases were followed prospectively and there were no retrospective cases that reached the 10-year time point, only 12 prospective cases had 10-year data.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Stryker JR Clinical Research | Stryker Orthopaedics | 201-831-5000 | StrykerJRClinical@stryker.com |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP_ICF | Yes | Yes | Yes | Study Protocol, Statistical Analysis Plan, and Informed Consent Form | Sep 26, 2019 | Jun 6, 2023 | Prot_SAP_ICF_000.pdf |
Not provided
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Paul Jacob, MD |
| Oklahoma Sports Science and Orthopaedics |
| Principal Investigator |
| Egg Harbor |
| New Jersey |
| 08234 |
| United States |
| Department of Orthopaedic Surgery, Kaleida Health, Buffalo General Hospital | Buffalo | New York | 14203 | United States |
| Syracuse Orthopedic Specialists | Syracuse | New York | 13214 | United States |
| Rothman Institute | Media | Pennsylvania | 19063 | United States |
| Mansfield Orthopaedics | Morrisville | Vermont | 05661 | United States |
| Praxisklinik Stollberg und Arthro. Zentrum GmbH | Stollberg | 09366 | Germany |
| Presidlo Ospedaliero Civile Santi Antonio e Biagio | Alessandria | 15100 | Italy |
| Hassleholm Sygehus Ortopaedkirurgisk afd. Esplanadgatan | Hässleholm | Sweden |
| Adverse Event |
|
| Sponsor terminated early |
|
| Censored because surgery not done |
|
| Censored because study device was not implanted |
|
| Censored because of Inclusion/exclusion violation |
|
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
All subjects enrolled will receive the Triathlon PKR device. Triathlon PKR: Triathlon PKR is a unicondylar knee resurfacing system designed to replace a single osteoarthritic compartment of a patient's natural knee for a primary replacement indication. |
|
|
| Secondary | 10-years Kaplan Meier Survival Analysis | For the purpose of this study the Kaplan-Meier survival curves are a statistical method to estimate the survival function from lifetime data of a knee replacement after treatment. Survivorship is defined as a percentage of knees free of any component revision for any reason. | This primary outcome measure at 10 years is a statistical estimation based on 80 prospective knees as per the protocol. | Posted | Number | 95% Confidence Interval | percentage of knees | 10-years | Knees | Knees |
|
|
|
| 0 |
| 89 |
| 11 |
| 89 |
| 26 |
| 89 |
| EG001 | Non-Operative Adverse Events | Non-operative site adverse events are reported by participant. | 1 | 88 | 20 | 88 | 0 | 88 |
| Non-operative | Gastrointestinal disorders | MedDRA | Non-systematic Assessment |
|
| Non-operative | General disorders | MedDRA | Non-systematic Assessment |
|
| Operative site | Injury, poisoning and procedural complications | MedDRA | Non-systematic Assessment |
|
| Operative site | Musculoskeletal and connective tissue disorders | MedDRA | Non-systematic Assessment |
|
| Non-operative | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA | Non-systematic Assessment |
|
| Non-operative site | Psychiatric disorders | MedDRA | Non-systematic Assessment |
|
| Non-operative | Renal and urinary disorders | MedDRA | Non-systematic Assessment |
|
| Non-operative | Respiratory, thoracic and mediastinal disorders | MedDRA | Non-systematic Assessment |
|
| Non-operative | Vascular disorders | MedDRA | Non-systematic Assessment |
|
There is an agreement between Principal Investigators and the Sponsor (or its agents) that requires Investigators to allow Sponsor at least 60 days to review material intended for publications to ensure that confidential information is not disclosed and that the data is accurately represented. The investigators can submit publication proposals prior to the study completion date for Sponsor consideration and for up to 7 years after study completion.